Navigation Links
Introduction of New Products and Increased Uptake of Innovative Materials to Drive US Bone Graft Substitute Market to Nearly $2.3 Billion by 2015
Date:9/21/2010

TORONTO, Sept. 21 /PRNewswire/ -- According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the introduction and adoption of new growth factors, combined with greater variety and improved features of newer products, will drive the US bone graft substitute market to nearly $2.3 billion through 2015.

Medtronic Spinal & Biologics' new bone morphogenetic protein, AMPLIFY, is set to be released in the US market in 2011. Unlike INFUSE, however, AMPLIFY is combined with a collagen and ceramic matrix designed for implantation in single-level posterolateral lumbar fusions—an indication that current bone morphogenetic proteins do not have approval for. BioMimetic Therapeutics' Augment Bone Graft is also set to enter the US market in 2011. The device's platelet-derived growth factor is touted by BioMimetic Therapeutics for having five times the rate of chemotaxis (the ability to recruit stem cells) and the ability to stimulate the replication of osteoblasts, not normally typical of bone morphogenetic proteins.

Orthopedic stem cell products, such as NuVasive's Osteocel Plus, Orthofix's Trinity Evolution, or AlloSource's AlloStem, contain stem cells that can differentiate into a variety of tissue cells to promote bone healing. Such products offer superior effectiveness compared with many alternative substitutes. Second-generation synthetic products, such as Orthovita's Vitoss BA and Baxter's Actifuse have integrated bioactive components that increase osteoinductivity and thus accelerate bone growth and healing. The improved features of these products will promote surgeon adoption of these materials over autografts, while their higher prices compared to older generation products will contribute to revenue growth over the next five years.

"Surgeons certainly have a plethora of choice when it comes to bone graft substitutes," says Deanna Vankessel, Senior Analyst at MRG. "The increased marketing that will follow the pending approval of AMPLIFY and Augment will contribute to even greater awareness of all of the viable alternatives to the conventional, yet gold-standard, autograft harvesting technique."

MRG's US Markets for Orthopedic Biomaterials 2010 report provides critical insight into emerging trends that will fuel product adoption and market growth for bone graft substitutes, hyaluronic acid viscosupplementation, machined bone interbody devices, cell concentration systems, and knee cartilage repair treatments in the US through 2015. Additionally, the report provides a complete breakdown of procedure volumes, unit sales, average selling prices, and revenues by device type. This report includes five-year forecasts, up-to-date market shares, and in-depth qualitative insights.

About Millennium Research Group
Millennium Research Group (www.MRG.net), a Decision Resources, Inc. company (www.DecisionResourcesInc.com), is the global authority on medical technology market intelligence and the leading provider of strategic information to the health care sector. The company provides specialized industry expertise through multiclient market research, ongoing Marketrack™ projects, customer behavior tracking, facility-level procedure forecasting, and customized solutions.

About Decision Resources, Inc.Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information, and insights on important sectors of the health care industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at www.DecisionResourcesInc.com.

All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.For more information, contact:Amy KrohnMillennium Research Group416-364-7776 ext. 101akrohn@mrg.netChris Comfort
Decision Resources Inc.
781-993-2597
ccomfort@dresources.com
'/>"/>

SOURCE Millennium Research Group
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. ConvaTec Expands AQUACEL® Dressing Product Line With Introduction of New Ribbon Dressing
2. Halozyme Provides HYLENEX® Product Reintroduction Update
3. OrthoAccel Technologies, Inc. and AB Orthodontics Announce Partnership and Australian Product Introduction
4. RegenceRx Leads the Industry With Introduction of Medication Cost Integration
5. Bioniche Pharma and Academic Pharmaceuticals, Inc. Announce the Introduction of Sotalol Hydrochloride Injection
6. Using Internal Communications to Help Build a Credible External Message Regarding New Pharmaceutical Products
7. Waters Introduces Ostro Sample Preparation Products
8. Reportlinker Adds The Global Orthobiologics Market - Players, products and technologies driving change 2008
9. Magic-Seal Packaging Products to Introduce First Vytex® Natural Rubber Latex Napkin Rings
10. Henry Schein Provides Health Care Products for Relief After Flooding in Pakistan
11. Frost & Sullivan Applauds the Lodox Statscan Critical Imaging System for Outperforming All Competing Products
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... -- Varian Medical Systems (NYSE: VAR ) announced ... of fiscal year 2017 following the close of regular trading ... followed by a teleconference available to all interested parties at ... the conference call webcast will be available on the company ... and replay: ...
(Date:3/29/2017)...  NuVasive, Inc. (NASDAQ: NUVA), a leading medical ... minimally disruptive, procedurally-integrated solutions, today announced U.S. Food ... CoRoent® Small Interbody™ System indicated for intervertebral body ... spine. This marks the first U.S. clearance for ... to four contiguous levels. Cervical radiculopathy ...
(Date:3/29/2017)... 2017 NetworkNewsWire Editorial Coverage  ... There are a ... regulating marijuana, but economic arguments also favor its legalization. The ... enforcement costs. However, to legalize and regulate marijuana requires an ... (OTC: SING) ( SING Profile ), American Cannabis Company (OTC: ...
Breaking Medicine Technology:
(Date:3/29/2017)... ... March 29, 2017 , ... The Professional ... it has enlisted New York City-based sports and entertainment marketing firm Leverage Agency ... sponsorship opportunities for the Professional Squash Association (PSA), which includes first-time ever title ...
(Date:3/29/2017)... ... March 30, 2017 , ... Sublime Naturals and its founder, Kathy ... "Wonder Spice", it has been used for thousands of years. , "The West has ... author of " Turmeric: How to Use it For Your Wellness. Overcome Inflammation, Enemy ...
(Date:3/29/2017)... ... March 29, 2017 , ... ... provides insight into the challenges employers face in trying to balance both short-term ... employee benefits programs? Adding to the growing complexity, companies are finding that ...
(Date:3/29/2017)... ... March 29, 2017 , ... ... documenting and diagramming network and data center assets and audio-video devices has recently ... request new equipment shapes for free and download shapes and stencils from ...
(Date:3/29/2017)... ... March 29, 2017 , ... Immunotherapy has emerged as one of ... and is touted to be the next revolution in our fight against this complex ... the form of immune checkpoint inhibitors such as PD-1 and PD-L1 inhibitors. , While ...
Breaking Medicine News(10 mins):